Beyond RECIST: rethinking endpoints and biomarkers for educative cancer therapy.
Non-cytotoxic cancer therapies increasingly seek to control malignant systems rather than maximize tumor-cell killing. Educative strategies aim to impose or restore less harmful states such as dormancy, differentiation, tumor microenvironment normalization or reduced invasion. Pressure-dependent evolutionary containmen...